Structure of the Clostridium perfringens GH89 in complex with alpha-HNJNAc

Sha Zhu (Contributor)
Yerri Jagadeesh (Contributor)
Anh Tuan Tran (Contributor)
Shuki Imaeda (Contributor)
Alisdair Boraston (Contributor)
D. S. Alonzi (Contributor)
Ana Poveda (Contributor)
Yongmin Zhang (Contributor)
J. Désiré (Contributor)
Julie Charollais-Thoenig (Contributor)
Stéphane Demotz (Contributor)
Atsushi Kato (Contributor)
Terry D. Butters (Contributor)
Jesús Jiménez-Barbero (Contributor)
Matthieu Sollogoub (Contributor)
Y. Blériot (Contributor)

Hospital Pharmacy

Dataset

Date made available	2021/07/28
Publisher	Protein Data Bank (PDB)

DOI
10.2210/pdb7MFK/pdb

Access Dataset

https://www.wwpdb.org/pdb?id=pdb_00007mfk

1 Article

Iminosugar C-Glycosides Work as Pharmacological Chaperones of NAGLU, a Glycosidase Involved in MPS IIIB Rare Disease**
Zhu, S., Jagadeesh, Y., Tran, A. T., Imaeda, S., Boraston, A., Alonzi, D. S., Poveda, A., Zhang, Y., Désiré, J., Charollais-Thoenig, J., Demotz, S., Kato, A., Butters, T. D., Jiménez-Barbero, J., Sollogoub, M. & Blériot, Y., 2021/08/05, In: Chemistry - A European Journal. 27, 44, p. 11291-11297 7 p.
Research output: Contribution to journal › Article › peer-review

Open Access
6 Scopus citations

Cite this

Zhu, S. (Contributor), Jagadeesh, Y. (Contributor), Tran, A. T. (Contributor), Imaeda, S. (Contributor), Boraston, A. (Contributor), Alonzi, D. S. (Contributor), Poveda, A. (Contributor), Zhang, Y. (Contributor), Désiré, J. (Contributor), Charollais-Thoenig, J. (Contributor), Demotz, S. (Contributor), Kato, A. (Contributor), Butters, T. D. (Contributor), Jiménez-Barbero, J. (Contributor), Sollogoub, M. (Contributor), Blériot, Y. (Contributor) (2021/07/28). Structure of the Clostridium perfringens GH89 in complex with alpha-HNJNAc. Protein Data Bank (PDB). 10.2210/pdb7MFK/pdb

Structure of the Clostridium perfringens GH89 in complex with alpha-HNJNAc

DOI

Access Dataset

Research output

Iminosugar C-Glycosides Work as Pharmacological Chaperones of NAGLU, a Glycosidase Involved in MPS IIIB Rare Disease**

Cite this